Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
Sharing Insights at the 'Italy on the Move' Event and Engaging Investors at Biotech Showcase During JPM Healthcare Week in...
Cancer
Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
Partnership Delivers Advanced Radioligand Treatments Across Asia-Pacific, Expanding Access to Cutting-Edge Cancer Therapies TAIPEI, Taiwan, Jan. 09, 2025 (GLOBE NEWSWIRE)...
Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma
New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma Sarclisa SC formulation added...
Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
Partnership Delivers Advanced Radioligand Treatments Across Asia-Pacific, Expanding Access to Cutting-Edge Cancer Therapies TAIPEI, Taiwan, Jan. 08, 2025 (GLOBE NEWSWIRE)...
Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
Partnership Delivers Advanced Radioligand Treatments Across Asia-Pacific, Expanding Access to Cutting-Edge Cancer Therapies TAIPEI, Taiwan, Jan. 09, 2025 (GLOBE NEWSWIRE)...
Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BOSTON and SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation (“Frontier” or the “Company”), a...
Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening
-A screening indication for women with dense breast tissue adjunctive to 3D mammography increases the market size for annual IzoView...
Roche’s momentum in digital pathology continues with FDA clearance on its high-volume slide scanner
The VENTANA DP 600 slide scanner, part of Roche's Digital Pathology Dx system, is now cleared by the FDA to...
TestoPrime Review: Why TestoPrime Is Better Than Other Testosterone Booster Supplement in 2025?
TestoPrime is a top rated, all natural testosterone booster for men in their 40's and 50's looking to boost energy,...
RiDYMO® Designs Cyclic Peptide for “Undruggable” β-Catenin Target Within Two Months
BEIJING, Jan. 8, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide...
ITRI Opens CES 2025 With Trend-Leading Showcase and Partnership With Reliance Biotech Corporation
LAS VEGAS, Jan. 8, 2025 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI) initiated its presence at CES 2025 with an...
Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options
VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to...
DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference
Leader in liquid biopsy, cancer screening, and monitoring speaks at largest healthcare investment symposium BALTIMORE and PALO ALTO, Calif., Jan....
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease
Largest DxA investment to date supports development of Alamar's ARGO™ DX System and future in vitro diagnostic tests NEW YORK...
ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities
Research Published in Radiology Shows that Combination of Transpara-based Lesion Detection, Volumetric Density and Quantitative Texture Analysis Delivers Improved Breast...
Hartford HealthCare and Aidoc Partner to Transform Patient Care with Enterprise AI
The partnership reached initial go-live in three weeks, showcasing the impressive speed and scalability of Aidoc's aiOS™ platform HARTFORD, Conn.,...
Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform
Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational...
Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase
SAN FRANCISCO, CA / ACCESSWIRE / January 8, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the...
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the...
Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors
CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today...